Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietin

W Fried1

  • 1Section of Hematology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.

Annual Review of Nutrition
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Erythropoietin (Epo) is a key hormone regulating red blood cell production, primarily produced by the kidneys. Recombinant human Epo (rHuEpo) effectively treats various anemias, though further research on Epo regulation and use is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monitoring silver diamine fluoride application with optical coherence tomography.

Proceedings of SPIE--the International Society for Optical Engineering·2021
Same author

Studies on erythropoiesis.

Progress in nuclear energy. Series 6 Biological sciences·2014
Same author

Psychiatry Today : Biology vs. Psychology.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

Prof. A. Wischnjewski's Novocaine Block Treatment Method.

Das Deutsche Gesundheitswesen·2010
Same author

Vertical distraction of fibula transplant in a case of mandibular defect caused by shotgun injury.

International journal of oral and maxillofacial surgery·2006
Same author

[Evaluation of individual ceramic implants made of Bioverit with CAD/CAM technology to reconstruct multidimensional craniofacial defects of the human skull].

Mund-, Kiefer- und Gesichtschirurgie : MKG·2006
Same journal

Mechanisms of NAD+ Homeostasis in Aging and Disease.

Annual review of nutrition·2026
Same journal

Metabolite Damage and Repair in Health and Disease.

Annual review of nutrition·2026
Same journal

From Food to Function: Cross-Kingdom Transfer and Regulatory Potential of Dietary microRNAs Highlighted by Breast Milk.

Annual review of nutrition·2026
Same journal

The Influence of Diet on Cancer Progression and Treatment.

Annual review of nutrition·2026
Same journal

The Potential Physiologic Mechanisms by Which Early-Life Nutrition May Influence Type 2 Diabetes Pathophysiology in Humans.

Annual review of nutrition·2026
Same journal

The Paradox and Future of GLP-1/GIP Combination Therapies: Efficacy and Mechanisms.

Annual review of nutrition·2026
See all related articles

Area of Science:

  • Endocrinology
  • Hematology
  • Renal Physiology

Background:

  • Erythropoietin (Epo) is the first discovered growth factor, an endocrine hormone synthesized by renal cells.
  • Epo production is primarily dictated by renal cell oxygen supply/demand but modulated by other factors.
  • Epo acts on erythroid progenitors, promoting proliferation and maturation into red blood cells.

Purpose of the Study:

  • To review the fundamental aspects of erythropoietin (Epo) production and function.
  • To discuss the therapeutic applications of recombinant human Epo (rHuEpo) in anemia treatment.
  • To highlight areas requiring further investigation in Epo biology and clinical use.

Main Methods:

  • Literature review of erythropoietin (Epo) physiology and clinical applications.

Related Experiment Videos

  • Analysis of existing data on recombinant human Epo (rHuEpo) efficacy and safety.
  • Synthesis of current knowledge on Epo regulation and therapeutic potential.

    • Main Results:

    • Erythropoietin (Epo) production is sensitive to oxygen levels and influenced by multiple systemic factors.
    • Recombinant human Epo (rHuEpo) is a safe and effective treatment for anemia in renal failure and other conditions.
    • Epo's role in various anemias, including those associated with neoplasms and myelodysplastic syndromes, has been established.

    Conclusions:

    • Erythropoietin (Epo) is a critical regulator of erythropoiesis with significant therapeutic value.
    • Recombinant human Epo (rHuEpo) has revolutionized anemia management in diverse clinical settings.
    • Further research is essential to fully elucidate Epo's regulatory mechanisms and optimize its clinical application.